Maravai Lifesciences Holdings (MRVI) Operating Expenses (2020 - 2026)

Maravai Lifesciences Holdings' Operating Expenses history runs 7 years deep, the most recent figure standing at $35.9 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 36.96% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $267.9 million (down 32.13% YoY), while the FY2025 annual figure was $249.3 million, down 27.53% from the prior year.
• Operating Expenses for Q1 2026 stood at $35.9 million, down from $71.6 million in the prior quarter.
• The five-year high for Operating Expenses was $197.8 million in Q3 2024, with the low at -$67.5 million in Q4 2023.
• The 5-year median for Operating Expenses is $76.5 million (2023), against an average of $72.1 million.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 170.65% in 2023, then soared 184.64% in 2024.
• Maravai Lifesciences Holdings' Operating Expenses stood at $95.5 million in 2022, then sank by 170.65% to -$67.5 million in 2023, then jumped by 184.64% to $57.1 million in 2024, then grew by 25.48% to $71.6 million in 2025, then tumbled by 49.94% to $35.9 million in 2026.
• Business Quant data shows MRVI's Operating Expenses at $35.9 million in Q1 2026, $71.6 million in Q4 2025, and $46.7 million in Q3 2025.